Original Article
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jul 14, 2014; 20(26): 8535-8544
Published online Jul 14, 2014. doi: 10.3748/wjg.v20.i26.8535
Table 1 Demographics and clinical characteristics of 153 patients n (%)
CharacteristicValue
Age (yr), mean (range)65.2 (28-89)
Male/female101/52
Preoperative symptom(s)37 (24)
Diabetes mellitus (preoperative )39 (25)
History of pancreatitis20 (13)
Body mass index, mean ± SD22.5 ± 3.5
Procedure
Pancreatoduodenectomy103
Distal pancreatectomy50
Resection of the portal vein21 (14)
Pathological diagnosis
Invasive carcinoma of the pancreas68
Intraductal papillary mucinous neoplasm35
Carcinoma of the ampulla13
Cholangiocarcinoma10
Pancreatic neuroendocrine tumor8
Other19
Grade of postoperative pancreatic fistula1
A76
B70
C7
Table 2 Inflammatory markers for clinically relevant postoperative pancreatic fistulas
MarkerPOD 1
POD 3
POD 5
Change from POD 1 to 3
Change from POD 3 to 5
AUCP valueAUCP valueCutoffAUCP valueAUCP valueCutoffAUCP value
White blood cell count (/mm3)0.5450.3430.5240.615114000.5880.0670.5040.9396000.5570.242
Neutrophil count (/mm3)0.5600.1980.5320.49582000.5910.0600.5060.898-33000.5600.215
Total lymphocyte count (/mm3)0.5240.6040.5770.0976000.5410.3970.5500.28500.5180.708
Platelet count (/mm3)0.5400.3990.6150.0141640000.5800.0980.6030.028-240000.5490.310
Serum amylase (IU/mL)0.5040.9350.5800.0871360.6000.0390.5020.966-690.5220.643
C-reactive protein (mg/L)0.5340.5320.688< 0.0011580.684< 0.0010.767< 0.00128.40.5650.200
Procalcitonin (ng/mL)--0.5840.4510.3-------
Neutrophil-to-lymphocyte ratio0.5320.4970.5790.0929.60.5900.0610.5370.433-0.30.5580.420
Platelet to lymphocyte ratio0.5170.7180.5290.5572310.5570.2430.5080.858670.5390.231
Table 3 Diagnostic value of clinical factors for clinically relevant postoperative pancreatic fistula
VariableUnivariate
Multivariable
Odds ratio95%CIP valueOdds ratio95%CIP value
Age (≥ 65 yr)1.160.61-2.230.654
Gender (male)1.290.66-2.530.459
Diabetes mellitus1.390.67-2.920.378
History of pancreatitis0.620.23-1.590.321
Body mass index (≥ 22)1.480.79-2.820.226
Operative procedure (DP)1.650.83-3.280.151
Invasive carcinoma of the pancreas2.311.21-4.470.0112.941.08-8.550.035
Operative time (≥ 360 min)1.330.71-2.530.376
Blood loss (≥ 600 mL)1.830.97-3.510.0631.730.62-4.860.297
Intraoperative transfusion1.450.48-4.590.511
Pancreas texture (soft)1.460.69-3.100.322
Main pancreatic duct (< 4 mm)1.360.70-2.650.366
Persistence of high fever (≥ 38 °C, ≥ 3 d)1.100.57-2.140.781
Persistence of SIRS (≥ 3 d)1.680.88-3.230.116
Usage of catecholamines1.730.68-4.620.251
Total lymphocyte count (< 600/mm3, POD 3)1.730.74-4.230.201
Platelet count (< 164000/mm3, POD 3)2.281.20-4.390.0121.280.44-3.640.646
CRP (≥ 158 mg/L, POD 3)4.822.37-10.2< 0.0012.390.73-8.030.150
Neutrophil-to-lymphocyte ratio (≥ 9.6, POD 3)1.840.97-3.520.0611.560.55-4.400.401
CRP elevation (≥ 28.4 mg/L, POD 1 to 3)11.44.35-34.3< 0.0014.821.25-20.20.022
Drain amylase (≥ 1918 IU/mL, POD 3)3.001.57-5.860.0011.500.55-4.080.423
Drain fluid bacterial culture (positive, POD 3)1.620.68-3.870.278
Table 4 Comparison of diagnostic performance of potent factors for clinically relevant postoperative pancreatic fistula
Odds ratio95%CIP valueSensitivitySpecificityPositive predictive valueNegative predictive valueLikelihood ratio of positive resultLikelihood ratio of negative result
CRP ≥ 158 mg/L14.822.37-10.2< 0.0010.5940.7670.7070.6672.5520.529
CRP elevation ≥ 28.4 mg/L211.44.35-34.3< 0.0010.8640.6430.6550.8572.4180.212
Drain amylase ≥ 1918 IU/mL13.001.57-5.860.0010.6360.6320.6360.6321.7270.576
Risk score ≥ 812.95.13-35.4< 0.0010.7950.7680.7290.8273.4270.266